Chen et al. found that compared with the control group, the expression of CD8 and CD86 in tumor tissue and peripheral blood of ESCA patients decreased significantly, suggesting that impaired immune function and reduced number of dendritic cells are the potential causes of the occurrence and development of ESCA (Chen et al., 2004). The gene discussed is CD86; the disease is neoplasm.